Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 256,193Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 45UNITED THERAP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 9393203

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code : U-1877

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-04-27

blank

02

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 9393203

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code : U-1877

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-04-27

blank

03

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 8747897

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code : U-2725

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-11

blank

04

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 8747897

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code : U-2724

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-11

blank

05

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 8747897

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code : U-2725

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-11

blank

06

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 8747897

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code : U-2724

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-11

blank

07

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 8747897

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code : U-2724

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-11

blank

08

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 8747897

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code : U-2725

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-11

blank

09

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 8747897

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code : U-2725

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-11

blank

10

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 8747897

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code : U-2724

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-11

blank